Dr Reddy's Laboratories received a Form 483 from the US Food and Drug Administration (USFDA) following the completion of a pre-approval inspection at its FTO-11 manufacturing facility in Pydibhimavaram. The regulator cited two observations in the document.

Inspection outcome and company response

The USFDA concluded its inspection of the FTO-11 facility and issued the Form 483 carrying two observations. The inspection was identified as a pre-approval inspection, indicating it was conducted to evaluate the facility for potential product approval. Dr Reddy's Laboratories has stated its intention to address and resolve the observations within the timeframe provided by the regulator.

About Form 483

A Form 483 is a document issued by the USFDA at the conclusion of an inspection when investigators observe conditions that may constitute violations of regulations. Receipt of a Form 483 does not constitute a final agency determination of non-compliance, and companies are typically given an opportunity to respond with corrective actions.

A large-trade signal flagged approximately 2,02,198 shares of Dr Reddy's Laboratories changing hands on the NSE at ₹1,219.00 per share, with a combined value of ₹24.65 crore.

This is a real-time large-trade signal, not a confirmed block or bulk deal. NSE/BSE publish official block and bulk deal reports only after market close — this trade may or may not appear there.

Trade details

The signal reflects a cluster of trades in Dr Reddy's Laboratories printed within a short window at or near ₹1,219.00, flagged by a real-time trade-scanning system for size and speed. No buyer, seller, broker, or client identity is available at this stage, as such disclosures are made only by the exchange after market close.

What this signal means

This activity is generated by a real-time trade-scanning system and is not, by itself, evidence of a confirmed exchange-level event. Official disclosures follow separate regulatory processes and timelines.

What this is, and isn't: this reflects trade-level activity — a cluster of trades in the stock above, printed within a short window at or near the quoted price, for a combined value as stated. It is generated by our real-time trade-scanning system and is not, by itself, evidence of a block or bulk deal.

A block deal has to be executed in the exchange's dedicated window (8:45–9:00am or 2:05–2:20pm), within a set price band, and above the current minimum order size (₹25 crore). A bulk deal is when one client's total trading in a stock crosses 0.5% of its equity in a single day — confirmed only once every trade that client made is added up.

Both are published by NSE/BSE after trading hours end, typically after 3:30pm — never before. If this trade qualifies as either, it will appear in the exchange's own report later today, not here first.